Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study-Reference-Cited by-同舟云学术

Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

Published:2007-11 Issue:9601 Volume:370 Page:1757-1763
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Vesikari T,Karvonen A,Prymula R,Schuster V,Tejedor JC,Cohen R,Meurice F,Han HH,Damaso S,Bouckenooghe A

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Rotavirus and severe childhood diarrhoea;Parashar;Emerg Infect Dis,2006

2. Burden of rotavirus disease in European Union countries;Soriano-Gabarro;Pediatr Infect Dis J,2006

3. Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12;Bernstein;Vaccine,1998

4. Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial;Bernstein;Lancet,1999

5. Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants;Bernstein;J Infect Dis,2002

Cited by 559 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18–49 years to assess safety and preliminary observation of immunogenicity;Vaccine;2024-07

2. A Probiotic Bacterium with Activity against the Most Frequent Bacteria and Viruses Causing Pediatric Diarrhea: Bifidobacterium longum subsp. infantis CECT 7210 (B. infantis IM1®);Microorganisms;2024-06-11

3. Impact of rotavirus vaccination on diarrheal disease burden of children in South America;Expert Review of Vaccines;2024-05-31

4. Vaccine targeting to mucosal lymphoid tissues promotes humoral immunity in the gastrointestinal tract;Science Advances;2024-05-31

5. Mucosal vaccines for viral diseases: Status and prospects;Virology;2024-05